MoneyWorks4Me

Choksi Laboratories informs about updates

23 Nov 2022 Evaluate
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements), 2015, as amended vide SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, Choksi Laboratories has informed that it enclosed details on Related Party Transactions on a consolidated basis for the Half-year ended 30th September 2022, drawn in accordance with applicable accounting standards.

The above information is a part of company’s filings submitted to BSE.

Choksi Laboratories Share Price

151.20 6.95 (4.82%)
01-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Indegene 605.80
Syngene Internatl. 401.65
JITF Infralogistics 309.50
CMS Info Systems 247.65
Sagility 46.31
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: